Abstract
Ten children, 3 to 15 years of age with high risk primary brain tumors were treated with postradiation ‘eight in one’ chemotherapy; vincristine, lomustine, procarbazine, hydroxyurea, cisplatin, cytosine arabinoside, cyclophosphamide and methylprednisolone. The tumors comprised of three medulloblastomas, two primitive neuroectodermal tumors, one ependymoblastoma and four anaplastic ependymomas. Treatment involved surgery (two total resection, six subtotal and two biopsy only) followed by conventional radiotherapy (primary tumor: 50–54 Gy, whole brain: 30–45 Gy, and spinal axis: 25–36 Gy). Objective tumor response with radiotherapy was achieved in 7 of 9 patients (78%) (6/8 patients with residual tumor and one patient with complete resection but positive cerebrospinal fluid cytology). Complete response was attained in 4 of 9 patients (44%). ‘Eight in one’ chemotherapy was initiated four weeks after radiation and repeated at 4 weekly intervals for 5–8 courses. Postradiation ‘eight in one’ failed to show any additional effect on tumor responses. Median survival was 34 months (range 9–48 months) with five of ten patients alive: four in complete and one in partial remission. All the five survivors were among the patients who had achieved response to initial treatment. This result suggested that degree of response to initial treatment might determine subsequent outcome and thus the choice of modality for initial therapy might be important.
Similar content being viewed by others
References
Bloom HJG, Glees J, Bell J: The treatment and long-term prognosis of children with intracranial tumors: A study of 610 cases, 1950–1981. Int J Radiat Oncol Biol Phys 18: 723–745, 1990
Li FP, Winston KR, Gimbrere K: Follow-up of children with brain tumors. Cancer 54: 135–138, 1984
Cangir A, van Eys J, Berry DH, Hvizdala E, Morgan SK: Combination chemotherapy with MOPP in children with recurrent brain tumors. Med Pediatr Oncol 4: 253–261, 1978
Crafts DC, Levin VA, Edwards MS: Chemotherapy of recurrent medulloblastoma with combined procarbazine, CCNU, and vincristine. J Neurosurg 49: 589–592, 1978
Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, Ertel IJ, Kramer S, Chang CH, Leikin SL, Hammond D: The treatment of medulloblastoma: results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg 72: 572–582, 1990
Tait DM, Thornton-Jones H, Bloom JL, Lemerle J, Morris J: Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP1). Eur J Cancer 26: 464–469, 1990
Yung WA, Shapiro JR, Shapiro WR: Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42: 992–998, 1982
Goldie JH: New thoughts in resistance to chemotherapy. Hosp Pract 18: 165–177, 1983
Hill BT, Baserga R: The cell cycle and its significance for cancer treatment. Cancer Treat Rev 2: 159–175, 1975
Price LA, Hill BT: Safe and effective induction chemotherapy without cisplatin for squamous carcinoma of the head and neck. Impact on complete response rate and survival at five years following local therapy. Med Pediatr Oncol 10: 535–548, 1982
Pendergrass TW, Milstein JM, Geyer JR, Mulne AF, Kosnik EJ, Morris JD, Heideman RL, Ruymann FB, Stuntz JT, Bleyer WA: Eight drugs in one day chemotherapy for brain tumors: Experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol 5: 1221–1231, 1987
Allen JC, Helson L, Jereb B: Preradiation chemotherapy for newly diagnosed childhood brain tumors. A modified Phase II Trial. Cancer 52: 2001–2006, 1983
van Eys J, Cangir A, Coody D, Smith B: MOPP regimen as primary chemotherapy for brain tumors in infants. J NeuroOncol 3: 237–243, 1985
Duffner PK, Horowitz ME, Krischer JP, Friedman HS, Burger PC, Cohen ME, Sanford RA, Mulhern RK, James HE, Freeman CR, Seidel FG, Kun LE: Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725–1731, 1993
Mosijczuk AD, Nigro MA, Thomas PRM, Burger PC, Krischer JP, Morantz RA, Kurdunowicz B, Mulne AF, Towbin RB, Freeman AI, Nigro ED, Friedman HS, Kun LE: Preradiation chemotherapy in advanced medulloblastoma. Cancer 72: 2755–2762, 1993
Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G, Ryan J, Cohen BH, D'Angio G, Kramer ED, Zimmerman RA, Rorke LB, Evans AE, Schut L: Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 74: 433–440, 1991
Chang CH, Housepain EM, Herbert CJ: An operative staging system and a megavoltage radiation technique for cerebellar medulloblastoma. Radiology 93: 1351–1359, 1969
Iacuone JJ, Steinherz LJ, Ablin AR: Modifications for toxicity. In: Ablin AR (ed) Supportive Care of Children with Cancer. Current therapy and guidelines from the Children's Cancer Group. The Johns Hopkins University Press Baltimore and London, 1993, 37–57
Rosen G, Capparas B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mekta B, Urban C: Preoperative chemotherapy for osteogenic sarcoma. Cancer 49: 1221–1230, 1982
Hammond D, Sather H, Nesbit M, Miller D, Coccia P, Bleyer A, Lukens J, Siegel S: Analysis of prognostic factors in acute lymphoblastic leukemia. Med Ped Oncol 14: 124–134, 1986
Koscielniak E, Jurgens H, Winkler K, Burger D, Herbst M, Keim M, Bernhard G, Treuner J: Treatment of soft tissue sarcoma in childhood and adolescance: A report of the German Cooperative Soft Tissue Sarcoma Study. Cancer 70: 2557–2567, 1992
Kim TH, Chin HW, Pollan S, Hazel JH, Webster JH: Radiotherapy of primary brain stem tumors. Int J Radiat Oncol Biol Phys 6: 51–57, 1980
Kuhl J: Preliminary results of the German pilot trial HIT 88/89 in children and young adults with medulloblastoma. J Neuro-Oncol (Abstract) 12: 240, 1992
Rozental J, Trump D, Finlay J, Robins I, Steeves R, Langeland P, Schutta H: Pilot study of eight-drugs-in-one-day chemotherapy for high grade astrocytomas. J Neuro-Oncol (Abstract) 4: 115, 1986
Zeltzer P, Boyett J, Finlay J, Albright L, Wisoff J, Geyer R, McGuire P, Allen J, Rorke L, Stanley P, Stehbens J, Stevens K, Shurin S, Milstein J, Packer R, Bleyer A: Prognostic factors for survival in high risk PNETs in children: Report from CCG-921, Proc of ASCO (Abstract) 12: 415, 1993
Finlay J: An update on the brain tumor trials of the Children Cancer Study Group (CCSG). J Neuro-Oncol (Abstract) 12: 239, 1992
Rozental J, Robins I, Finlay J, Healey B, Levin AB, Steeves RA, Kohler PC, Schutta HS, Trump DL: 'Eight-drugs-inone-day: chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas. Cancer 63: 2475–2481, 1989
Boiardi A, Silvani A, Milanesi I, Broggi G, Fariselli L: Efficacy of ‘8-days-in-one-day’ combination in treatment of recurrent GBM patients. J Neuro-Oncol 12: 153–158, 1992
Deen DF, Chiarodo A, Grimm EA, Fike JR, Israel MA, Kun LE, Levin VA, Marton LJ, Packer RJ, Pegg AE, Rosenblum ML, Suit HD, Walker MD, Wikstrand CJ, Wilson CB, Wong AJ, Yung WKA: Brain Tumor Working Group Report on the 9th International Conference on Brain Tumor Research and Therapy. J Neuro-Oncol 16: 243–272, 1993
Jakacki R, Zeltzer P, Boyett J, Geyer J, Allen J, Finlay J, Albright A, Rorke L, Stanley P, Stevens K, Shurin S, McGuire P, Milstein J, Wisoff J, Stehbens J, Packer R, Bleyer A: Treatment and survival of pineoblastoma in childhood: Report of the Childrens Cancer Group Trial CCG-921. Proc ASCO (Abstract) 12: 415, 1993
Geyer JR, Pendergrass TW, Milstein JM, Bleyer WA: Eight drugs in one day chemotherapy in children with brain tumors. A critical toxicity appraisal. J Clin Oncol 6: 996–1000, 1988
Kretschmar CS, Warren MP, Lavally BL, Dyer S, Tarbeil NJ: Ototoxicity of preradiation cisplatin for children with central nervous system tumors. J Clin Oncol 8: 1191–1198, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ayan, I., Darendeliler, E., Kebudi, R. et al. Evaluation of response to postradiation eight in one chemotherapy in childhood brain tumors. J Neuro-Oncol 26, 65–72 (1995). https://doi.org/10.1007/BF01054770
Issue Date:
DOI: https://doi.org/10.1007/BF01054770